New Product Development
A recent study published by FMI anticipates that the global laband syndrome therapeutics market will grow at a compound annual growth rate (CAGR) of 5.2% between 2023 and 2033. The study projects that the market will reach a valuation of US$ 5 billion by the end of the assessment period. There is an increasing awareness …
Continue reading “Laband Syndrome Therapeutics Market is likely to register CAGR of 5.2% by 2033”
The global drug eruptions treatment market size is estimated to be valued US$ 3.89 billion in fiscal year 2023, compared to US$ 3.66 billion in fiscal year 2022. The global market is anticipated to increase steadily from 2023 to 2033 at a 6.2% CAGR, reaching US$ 7.1 billion by the end of that year. Skin …
The global Head and Neck Cancer (HNC) Therapeutics Market is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head and neck cancer (HNC) are expected to propel market expansion as they …
The global pork tapeworm infection treatment market will grow at an 8% CAGR from 2023 to 2033, reaching US$ 25.17 billion in 2033, according to Future Market Insights. The market is expected to grow further as the number of test kits and devices increases. The market for the treatment of pig tapeworm infection is likely …
Continue reading “Pork Tapeworm Infection Treatment Market is likely to register CAGR of 8% by 2033”
By 2023, the global intraocular lymphoma treatment market is estimated to be worth US$ 1.2 billion. According to market research firm Future Market Insights, the market will be worth US$ 2.3 billion by 2033 and will rise at a 6.7% CAGR. Intraocular lymphomas are rare tumours that can cause a variety of clinical signs. Its …
According to Future Market Insights, the global severe asthma treatment market is predicted to develop at a CAGR of 5.1% from 2023 to 2033. By 2033, the global market for severe asthma therapy is estimated to reach a value of US$ 36.18 billion. The discovery of biologics and other targeted medicines has transformed the treatment …
In 2022, the Hospital Workforce Management Market is projected to be worth US$1,413.8 million. Hospital workforce management is expected to increase at a CAGR of 10.6% between 2022 and 2032, reaching a total of about US$ 4,267.1 Million by 2032 in order to achieve the ideal hospital workforce while striking a fine balance between working staff and …
The global Digital Health Market is expected to reach a valuation of US$ 2585.98 Bn by 2032, with sales growing at an astounding CAGR of 27.7% from 2022 to 2032. Owing to the rising awareness of digital health benefits, the market for the same is likely to expand at a rapid rate and reach an …
By the end of 2022, it is anticipated that the global Helicobacter Pylori Testing Market will be worth US$173.1 Million. A CAGR of 7.4% has been predicted for the market over the forecast period of 2022 to 2032, with a predicted closing value of US$ 380.3 Million. The industry expanded at a value CAGR of …
With a 4.4% CAGR from 2022 to 2032, the Ureteral Stent Market is predicted to grow to US$ 385.9 million in 2022 and US$ 616.8 million by 2032. The demand for ureteral stents is increasing due to its ability to restore urine flow through blocked ureters caused by a variety of illnesses. This will lead …